| Mon, Oct 26, 2009 | | • | 4-Star Stocks Poised to Pop: Elan
at Motley Fool (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | Midday Movers: Pump Up the Volume
at TheStreet.com (Fri, Oct 23)
| | • | Biotech Stocks: Biogen, Elan fall on Tysabri drug woes
at MarketWatch (Fri, Oct 23)
| | • | Elan, Ramtron International: Biggest Price Decliners (ELN, RMTR)
at The Wall Street Journal Online (Fri, Oct 23)
| | • | Biogen, Elan fall; Dr. Reddy's rallies
at MarketWatch (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | Elan's Headed in the Right Direction
at Motley Fool (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | • | Elan Corporation, plc Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Oct 21)
| | • | Q3 2009 Elan Corporation, plc Earnings Release - Before Market Open
CCBN (Wed, Oct 21)
| | • | Elan Swings to Third-Quarter Profit
at TheStreet.com (Wed, Oct 21)
| | • | Elan swings to 3rd-qtr net on 6.3% higher revenue
at MarketWatch (Wed, Oct 21)
| | • | Elan Reports Third Quarter 2009 Financial Results
Business Wire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | All Tysabri, All the Time
at Motley Fool (Tue, Oct 20)
| | • | Biogen Reports Higher Profit
at TheStreet.com (Tue, Oct 20)
| | • | Biogen Reports Higher Q3 Profit
at TheStreet.com (Tue, Oct 20)
| | • | Immunostimulatory Antibodies Seen As Potential Treatment For Broad Range Of Cancers And Catalyst For Investment Returns By Ladenburg Thalmann Analyst
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Elan to Highlight Tysabri Data in Crohn's Disease at the American College of Gastroenterology Annual Scientific Meeting
Business Wire (Mon, Oct 19)
| | • | This Just In: Upgrades and Downgrades
at Motley Fool (Mon, Oct 19)
| | Fri, Oct 16, 2009 | | • | Baxter Beats Again -- the Streak Is Alive!
at Motley Fool (Fri, Oct 16)
| | Thu, Oct 15, 2009 | | • | Weak Dollar And Low Valuation To Boost J&J
at Investopedia (Thu, Oct 15)
| | • | Little Discord on Acorda Drug
at Motley Fool (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | • | Elan Corporation PLC Announces Results to Date of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
Business Wire (Wed, Oct 14)
| | Tue, Oct 13, 2009 | | • | [$$] J&J Net Rises Despite Drop in Drug Sales
at The Wall Street Journal Online (Tue, Oct 13)
| | • | J&J Needs to Get Drugged Up
at Motley Fool (Tue, Oct 13)
| | • | [$$] J&J Is Still OK
at Barrons.com (Tue, Oct 13)
| | • | 5 Stocks Approaching Greatness
at Motley Fool (Tue, Oct 13)
|
Add ELN News to My Yahoo!:
 
| |
|
0.46% Nasdaq 
Headlines
